BECN1 and colitis: As the results of ANOVA indicate, only time elapsed after TNBS administration had a significant effect on the reduction of LC3-II expression, while the induction of inflammation had a significant effect on Beclin-1 expression with a higher expression observed in the colitis group (ANOVA, p < 0.05; Figure S7).